Page 2 - Randall Stanicky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tyler Jacks, Ph.D., after 19 years. The director role will be taken over by Matthew Vander Heiden, M.D., Ph.D., a professor of biology at MIT and a medical oncologist at Dana-Farber Cancer Institute. He became a member of the Koch Institute in 2010 and took over for Jacks on Thursday, MIT said. Jacks will continue to lead the Bridge Project, which unites bioegnineers, cancer scientists and clinical oncologists from the Koch Institute and the Dana-Farber/Harvard Cancer Center. > Atara Biotherapeutics ushered Amie Krause into the role of senior vice president and chief people officer Apri...

Published: Apr 09, 2021 By Alex Keown Atara Biotherapeutics – Amie Krause was named Senior Vice President and Chief People Officer at Atara Biotherapeutics. In this role, Krause will be tasked with building a company culture that “rewards” values through actions and results. Prior to her tenure with Atara, Krause held several HR leadership positions at Amgen, including her role as Global HR Lead, Organizational Effectiveness during which she served as the human resources lead for Amgen’s global commercial operations covering the Americas, Europe, Asia, and the Middle East. Ps...

Aquestive Therapeutics, Inc. (AQST) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q4 2020 Earnings Call Ladies and gentlemen, thank you for standing by and welcome to the fourth quarter 2020 Aquestive Therapeutics Earnings Conference Call. [Operator instructions] Please be advised that today's conference may be recorded [Operator instructions] I would now like to hand the conference over to your speaker today, Ms. Stephanie Carrington. Ma'am, please go ahead. ...

Operator Ladies and gentlemen, thank you for standing by, and welcome to the Agile Therapeutics fourth-quarter and full-year 2020 financial results conference call. [Operator instructions] I'd now like to hand the conference over to your speaker today, Matt Riley, head of investor relations and corporate communications. Thank you. Please go ahead. Matt Riley -- Head of Investor Relations and Corporate Communications Hello, everyone, and welcome to today's conference call to discuss fourth-quarter and full-year 2020 financial results. Before we start, let me remind you that today's call will ...

Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Popular Searches Operator Good morning, everyone. My name is Leo and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals Fourth Quarter and Full-Year 2020 Financial Results and Pipeline Review Call. [Operator Instructions] After the speakers' remarks, there will be a question-and-answer period. [Operator Instructions] It is now my pleasu...